Understanding how herpesviruses package their genomes
Dissecting the mechanism of herpesvirus genome packaging
['FUNDING_OTHER'] · YALE UNIVERSITY · NIH-11066034
This study is looking into how the herpesvirus that causes Kaposi's sarcoma packs its genetic material, with the hope of finding new ways to create effective treatments for people dealing with this virus.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-11066034 on ClinicalTrials.gov |
What this research studies
This research investigates the mechanisms by which herpesviruses, particularly Kaposi's sarcoma-associated herpesvirus (KSHV), package their genetic material. The study aims to identify essential factors involved in this process using advanced techniques like proteomics and microscopy. By understanding these mechanisms, the research seeks to develop new antiviral strategies that could overcome the limitations of existing treatments, which often lead to resistance. The ultimate goal is to create a reliable in vitro assay for herpesvirus genome packaging that could facilitate the discovery of novel antiviral agents.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by herpesvirus infections, particularly those with compromised immune systems or those living in regions with high prevalence of KSHV.
Not a fit: Patients who are not infected with herpesviruses or those who do not have any related health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies that effectively target herpesviruses, potentially reducing the incidence of related diseases.
How similar studies have performed: Other research has shown promise in targeting viral packaging mechanisms, indicating that this approach could lead to significant advancements in antiviral therapies.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DIDYCHUK, ALLISON LOUISE — YALE UNIVERSITY
- Study coordinator: DIDYCHUK, ALLISON LOUISE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus